Worldwide distribution of HIV type 1 epitopes recognized by human anti-V3 monoclonal antibodies

AIDS Research and Human Retroviruses

Volumn 25, Issue 4, 2009, Pages 441-450

  Cardozo, Timothy ^a,d   Swetnam, James ^a   Pinter, Abraham ^b   Krachmarov, Chavdar ^b   Nadas, Arthur ^a   Almond, David ^a   Zolla Pazner, Susan ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ARTICLE; CRYSTAL STRUCTURE; DATA BASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS STRAIN;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; CONSENSUS SEQUENCE; CRYSTALLOGRAPHY; EPITOPE MAPPING; EPITOPES; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; WORLD HEALTH;

EID: 64849086846     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0188     Document Type: Article

References (25)

1. Barin F, Lahbabi Y, Buzelay L, Lejeune B, Baillou-Beaufils A, Denis F, Mathiot C, M'Boup S, Vithayasai V, Dietrich U, and Goudeau A: Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: An approach for HIV type 1 serological subtyping. AIDS Res Hum Retroviruses 1996;12(13):1279-1289.
2. Nyambi PN, Nadas A, Mbah HA, Burda S, Williams C, Gorny MK, and Zolla-Pazner S: Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes. J Virol 2000;74(22):10670-10680.
3. Mascola JR, Louwagie J, McCutchan FE, Fischer CL, He-gerich PA, Wagner KF, Fowler AK, McNeil JG, and Burke DS: Two antigenically distinct subtypes of human immunodeficiency virus type 1: Viral genotype predicts neutralization serotype. J Infect Dis 1994;169(1):48-54.
4. Pantophlet R and Burton DR: GP120: Target for neutralizing HIV-1 antibodies. Annu Rev Immunol 2006;24:739-769.
5. Gorny MK, Xu JY, Karwowska S, Buchbinder A, and Zolla-Pazner S: Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. J Immunol 1993;150(2):635-643.
6. Stanfield RL, Gorny MK, Williams C, Zolla-Pazner S, and Wilson IA: Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D. Structure 2004;12(2):193-204.
7. Zolla-Pazner S, Gorny MK, Nyambi PN, VanCott TC, and Nadas A: Immunotyping of human immunodeficiency virus type 1 (HIV): An approach to immunologic classification of HIV. J Virol 1999;73(5):4042-4051.
8. Gorny MK, Conley AJ, Karwowska S, Buchbinder A, Xu JY, Emini EA, Koenig S, and Zolla-Pazner S: Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J Virol 1992;66(12): 7538-7542.
9. Gorny MK, Williams C, Volsky B, Revesz K, Cohen S, Po-lonis VR, Honnen WJ, Kayman SC, Krachmarov C, Pinter A, and Zolla-Pazner S: Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades. J Virol 2002;76(18):9035-9045.
10. Osmanov S, Pattou C, Walker N, Schwardlander B, and Esparza J: Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 2002;29(2):184-190.
11. Buonaguro L, Tornesello ML, and Buonaguro FM: Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: Pathogenetic and therapeutic implications. J Virol 2007;81(19):10209-10219.
12. Hemelaar J, Gouws E, Ghys PD, and Osmanov S: Global and regional distribution of HIV-1 genetic subtypes and recom-binants in 2004. AIDS 2006;20(16):W13-23.
13. Stanfield RL, Gorny MK, Zolla-Pazner S, and Wilson IA: Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity. J Virol 2006;80(12):6093-6105.
14. Krachmarov CP, Honnen WJ, Kayman SC, Gorny MK, Zolla-Pazner S, and Pinter A: Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1. J Virol 2006;80(14):7127-7135.
15. Krachmarov CP, Kayman SC, Honnen WJ, Trochev O, and Pinter A: V3-specific polyclonal antibodies affinity purified from sera of infected humans effectively neutralize primary isolates of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 2001;17(18):1737-1748.
16. Connor RI, Chen BK, Choe S, and Landau NR: Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995; 206(2):935-944.
17. Haynes BF, Ma B, Montefiori DC, Wrin T, Petropoulos CJ, Sutherland LL, Scearce RM, Denton C, Xia SM, Korber BT, and Liao HX: Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates. Virology 2006;345(1): 44-55.
18. Keller PM, Arnold BA, Shaw AR, Tolman RL, Van Mid-dlesworth F, Bondy S, Rusiecki VK, Koenig S, Zolla-Pazner S, Conard P, et al.: Identification of HIV vaccine candidate peptides by screening random phage epitope libraries. Virology 1993;193(2):709-716.
19. Leitner T, Foley B, Hahn B, Marx P, McCutchan FE, Mellors J, Wolinsky S, and Korber B: HIV Sequence Compendium. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 2005, LA-UR 04-7420.
20. Cardozo T, Totrov M, and Abagyan R: Homology modeling by the ICM method. Proteins 1995;23(3):403-414.
21. Abagyan R and Totrov M: Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J Mol Biol 1994;235(3):983-1002.
22. Needleman SB and Wunsch CD: A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol 1970;48(3):443-453.
23. Saitou N and Nei M: The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 1987;4(4):406-425.
24. Zolla-Pazner, Zhong P, Revesz K, et al.: The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1. AIDS Res Hum Retroviruses 2004;20(11):1254-1258.
25. Osmanov S, Pattou C, Walker N, et al.: Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr. 2002;29(2): 184-190.